TriStar Technology Ventures, LLC

Description

The Device Innovation Group strategy is built on that of the existing MDI business model, which has a proven track record of successful commercialization in the medical device field.

Diagnovus is a molecular diagnostics company targeting rare forms of cancer, including pediatric cancers. Diagnovus is dedicated to developing diagnostic tests that will better inform physicians, payers, patients and families facing these difficult disease prospects. The company will identify, in-license, develop and commercialize diagnostic assays that have been developed at leading institutions around the US.

Dr. Jacobson has been a successful investor and entrepreneur having founded or co-founded ten companies. In addition, in his role at VUMC he participated in the oversight of technology transfer operations which resulted in the creation of over 30 companies.

Diagnovus, LLC’s first full-time employee will be James Stover, Ph.D. Dr. Stover is leaving his position as Vice President of Tennessee Technology Development Corporation and will join the Company as Vice President of Business Development. Prior to joining TTDC, Dr. Stover was a life science analyst with Square 1 Bank in San Diego, CA, and a senior research fellow in medicinal chemistry at the Scripps Research Institute. “I am delighted to join Diagnovus, LLC and begin working with the Limestone Fund and Tristar Technology Ventures.

Fact sheet

Products & services

Similar companies nearby